Dr. Oforbuike Ewelukwa, MD

NPI: 1891094561
Total Payments
$3,725
2024 Payments
$1,187
Companies
31
Transactions
143
Medicare Patients
2,156
Medicare Billing
$302,548

Payment Breakdown by Category

Food & Beverage$3,725 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,725 143 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $841.26 44 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $355.51 20 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $332.09 13 $0 (2024)
Allergan Inc. $277.49 4 $0 (2018)
Janssen Biotech, Inc. $202.14 7 $0 (2024)
Phathom Pharmaceuticals, Inc. $165.96 3 $0 (2024)
Ardelyx, Inc. $152.92 6 $0 (2024)
Gilead Sciences, Inc. $149.40 2 $0 (2024)
IRONWOOD PHARMACEUTICALS, INC $148.31 7 $0 (2024)
Intercept Pharmaceuticals, Inc. $136.15 6 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,187 44 ABBVIE INC. ($197.68)
2023 $654.09 33 ABBVIE INC. ($151.72)
2022 $517.03 18 Takeda Pharmaceuticals U.S.A., Inc. ($179.12)
2021 $280.47 9 BOSTON SCIENTIFIC CORPORATION ($124.99)
2020 $74.56 4 AbbVie Inc. ($41.51)
2019 $90.90 5 AbbVie, Inc. ($38.57)
2018 $556.31 24 AbbVie, Inc. ($202.41)
2017 $364.50 6 Allergan Inc. ($250.12)

All Payment Transactions

143 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
12/31/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $20.89 General
Category: Gastroenterology
12/05/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $8.04 General
Category: IMMUNOLOGY
11/27/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $32.96 General
11/27/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $21.64 General
Category: Gastroenterology
11/20/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $6.31 General
Category: IMMUNOLOGY
11/11/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $23.96 General
Category: ENDOCRINOLOGY
11/05/2024 Madrigal Pharmaceuticals REZDIFFRA (Drug) Food and Beverage In-kind items and services $118.96 General
Category: LIVER DISEASE
10/25/2024 CapsoVision, Inc. CapsoCam Plus (Device) Food and Beverage Cash or cash equivalent $18.40 General
Category: Gastroenterology
10/21/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $16.05 General
Category: GI
10/10/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $28.55 General
Category: GASTROENTEROLOGY
10/04/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $32.22 General
Category: Immunology
10/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $19.55 General
Category: Gastroenterology
09/26/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $18.59 General
Category: Gastroenterology
09/25/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $19.38 General
Category: ENDOCRINOLOGY
09/05/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $28.97 General
Category: GASTROENTEROLOGY
09/04/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $20.29 General
Category: GI
09/04/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $5.68 General
Category: ENDOCRINOLOGY
08/12/2024 ABBVIE INC. LINZESS (Drug), CREON, VIBERZI Food and Beverage In-kind items and services $21.93 General
Category: GASTROENTEROLOGY
07/31/2024 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $38.25 General
Category: Immunology
07/25/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $5.95 General
Category: IMMUNOLOGY
07/17/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $23.91 General
Category: GI
07/12/2024 CapsoVision, Inc. CapsoCam Plus (Device) Food and Beverage Cash or cash equivalent $14.33 General
Category: Gastroenterology
07/01/2024 ABBVIE INC. VIBERZI (Drug), LINZESS Food and Beverage In-kind items and services $21.45 General
Category: GASTROENTEROLOGY
06/20/2024 Gilead Sciences, Inc. Vemlidy (Drug) Food and Beverage In-kind items and services $116.44 General
Category: HBV
06/17/2024 ABBVIE INC. VIBERZI (Drug), LINZESS Food and Beverage In-kind items and services $21.53 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 513 647 $265,930 $68,618
2022 7 425 514 $226,958 $56,700
2021 10 534 702 $300,322 $83,168
2020 14 684 872 $317,312 $94,062
Total Patients
2,156
Total Services
2,735
Medicare Billing
$302,548
Procedure Codes
41

All Medicare Procedures & Services

41 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 101 175 $34,073 $16,654 48.9%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 78 84 $31,140 $11,584 37.2%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 52 100 $20,620 $9,198 44.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 74 74 $24,105 $8,616 35.7%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 43 44 $39,780 $8,588 21.6%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 67 71 $55,492 $6,484 11.7%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 52 53 $47,253 $3,939 8.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 21 21 $4,832 $1,496 31.0%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 13 13 $7,130 $1,182 16.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 12 12 $1,505 $875.40 58.2%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 94 101 $37,443 $16,093 43.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 66 101 $19,665 $9,812 49.9%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 60 98 $20,208 $8,062 39.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 60 60 $19,544 $7,702 39.4%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 34 36 $32,923 $6,273 19.1%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 68 73 $57,055 $5,934 10.4%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 43 45 $40,120 $2,824 7.0%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 148 164 $60,613 $27,121 44.7%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 100 177 $36,497 $15,039 41.2%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 67 120 $23,364 $12,222 52.3%
43239 Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 70 79 $61,745 $7,245 11.7%
45385 Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare Facility 2021 30 32 $29,265 $6,496 22.2%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 38 38 $12,378 $4,972 40.2%
43255 Control of bleeding of esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 17 21 $26,962 $3,525 13.1%
45380 Biopsy of the large bowel using an endoscope (colonoscopy) Facility 2021 42 43 $38,337 $2,890 7.5%

About Dr. Oforbuike Ewelukwa, MD

Dr. Oforbuike Ewelukwa, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Katy, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2011. The National Provider Identifier (NPI) number assigned to this provider is 1891094561.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Oforbuike Ewelukwa, MD has received a total of $3,725 in payments from pharmaceutical and medical device companies, with $1,187 received in 2024. These payments were reported across 143 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,725).

As a Medicare-enrolled provider, Ewelukwa has provided services to 2,156 Medicare beneficiaries, totaling 2,735 services with total Medicare billing of $302,548. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.

Practice Information

Products in Payments

  • STELARA (Biological) $256.62
  • ACZONE (Drug) $250.12
  • ENTYVIO (Biological) $222.75
  • VOQUEZNA (Drug) $165.96
  • TRULANCE (Drug) $158.96
  • ZEPOSIA (Drug) $153.48
  • IBSRELA (Drug) $152.92
  • LINZESS (Drug) $152.15
  • Linzess (Drug) $148.31
  • OCALIVA (Drug) $136.15
  • XIFAXAN (Drug) $136.06
  • VIBERZI (Drug) $126.92
  • GENERAL - THERAPIES (Device) $124.99
  • REZDIFFRA (Drug) $118.96
  • Vemlidy (Drug) $116.44
  • CREON (Drug) $115.72
  • Humira (Biological) $87.13
  • RINVOQ (Biological) $74.00
  • Entyvio (Biological) $69.31
  • SUTAB (Drug) $66.11

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Katy